NGNE
Neurogene Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Largest filed tie
0
filed ties
Fund move
Fund move
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−2.05%
vs ±13.1% implied · ×0.16
shaded = implied · ▲▼ = realized
Neurogene Inc.
27.61
No thesis.
Expected move
Inputs8Q avg ±6.2%·×2.89·rich
straddle ±20.4%
spot 27.55exp Nov 20ATM strike 30ATM straddle 6.60IV 115%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Samsara BioCapitalSamsara BioCapital | $54.0M | 9.84% | 0.00% | |
| 2 | Casdin CapitalCasdin Capital | $48.6M | 8.86% | +8.80% | |
| 3 | Redmile GroupRedmile | $44.4M | 8.09% | −3.25% | |
| 4 | RTW InvestmentsRTW | $42.8M | 7.81% | 0.00% | |
| 5 | EcoR1 CapitalEcoR1 Capital | $40.0M | 7.29% | 0.00% | |
| 6 | BlackRockBlackRockindex-like | $33.3M | 6.06% | +5.26% | |
| 7 | Baker Bros. AdvisorsBaker Bros. | $31.2M | 5.68% | 0.00% | |
| 8 | Balyasny Asset ManagementBalyasny | $25.7M | 4.69% | +13.96% | |
| 9 | Trails Edge Capital PartnersTrails Edge Capital Partners | $22.5M | 4.10% | −8.67% | |
| 10 | Toronto Dominion BankToronto Dominion Bank | $21.4M | 3.90% | 0.00% | |
| 11 | Vanguard Capital ManagementVanguardindex-like | $16.9M | 3.07% | +4.23% | |
| 12 | Jennison AssociatesJennison | $16.3M | 2.97% | −1.73% | |
| 13 | Citadel AdvisorsCitadel | $13.7M | 2.50% | +5.43% | |
| 14 | Great Point PartnersGreat Point Partners | $11.1M | 2.02% | −29.56% | |
| 15 | Arrowpoint Asset ManagementArrowpoint | $10.8M | 1.96% | −34.75% | |
| 16 | FMRFMR | $9.3M | 1.69% | −22.76% | |
| 17 | Geode Capital ManagementGeodeindex-like | $9.2M | 1.68% | +5.08% | |
| 18 | State StreetState Streetindex-like | $7.1M | 1.29% | −28.33% | |
| 19 | Franklin ResourcesFranklin Resources | $6.4M | 1.17% | new | |
| 20 | Morgan StanleyMorgan Stanley | $6.0M | 1.10% | −32.78% | |
| 21 | UBS GroupUBS | $5.4M | 0.98% | −7.75% | |
| 22 | Blair WilliamBlair William | $4.6M | 0.84% | −12.67% | |
| 23 | Driehaus Capital ManagementDriehaus | $4.5M | 0.82% | +338.05% | |
| 24 | Point72 Asset ManagementPoint72 | $4.5M | 0.81% | new | |
| 25 | Moore Capital ManagementMoore | $4.5M | 0.81% | new |
112 managers report $548.8M of Neurogene on form 13F for the quarter ended Jun 30 '26. 16 of them hold 80% of it; Samsara BioCapital is largest at 9.84%.